Randomised controlled trials for Ebola: practical and ethical issues
Clement Adebamowo(University of Maryland, Baltimore), John Whitehead(Lancaster City Council), Oumou Bah‐Sow(Laboratoire National de Santé), Abdul Tejan-Cole, Piero Olliaro(University of Oxford), Peter Horby, Aissatou Touré(United States Department of State), Roberto Bruzzone(Institut Pasteur), Arthur L. Caplan(Institute of Medical Ethics), Els Torreele(Instituut voor Landbouw en Visserijonderzoek), Fred Binka(University of Health and Allied Sciences), Jean‐Jacques Muyembe Tamfum(MACOM (United States)), Peter Piot(London School of Hygiene & Tropical Medicine), Pontiano Kaleebu(Uganda Virus Research Institute), Jean‐François Delfraissy, Oyewale Tomori(Redeemer's University)
Cited by 182
Related Papers
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19
|JAMA|2020|2.4k
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia
|New England Journal of Medicine|1986|1.5k
Connections with Connexins: the Molecular Basis of Direct Intercellular Signaling
|European Journal of Biochemistry|1996|1.3k